24/10/2020 - salute33

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

di salute33Pubblicazioni 24/10/2020Nessun commento

Christopher O. Barnes, – Claudia A. Jette, – Morgan E. Abernathy, – Kim-Marie A. Dam, – Shannon R. Esswein, – Harry B. Gristick,- Andrey G. Malyutin, – Naima G. Sharaf, – Kathryn E. Huey-Tubman, – Yu E. Lee, – Davide F. Robbiani, – Michel C. Nussenzweig, – Anthony P. West Jr & – Pamela J. Bjorkman Abstract The COVID-19 pandemic presents an urgent health crisis. Human neutralizing antibodies …

Leggi tutto “SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies”

Dieta ricca di flavanoli riduce la pressione del sangue

di salute33News, Nutrizione 24/10/202004/01/2022Nessun commento

A dirlo è uno studio realizzato dall’Università di Reading pubblicato sulla rivista Scientific Reports. Nella ricerca sono state analizzate 25.000 persone che vivono a Norfolk, nel Regno Unito ed è stata confrontata la loro alimentazione con la pressione del sangue. La differenza di pressione sanguigna tra quelli con il 10% più basso di assunzione di …

Leggi tutto “Dieta ricca di flavanoli riduce la pressione del sangue”

Cytokine Storms in Cancer and COVID-19

di salute33Pubblicazioni 24/10/2020Nessun commento

Main Text SARS-CoV-2 is the fifth betacoronavirus to infect humans and has led to the current COVID-19 pandemic. Over 30 million people have been infected worldwide, and mortality continues to rise to over 1 million. Cancer remains a worldwide disease, causing an estimated of 9.8 million deaths per year. “Cytokine storm” or “cytokine release syndrome” …

Leggi tutto “Cytokine Storms in Cancer and COVID-19”

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

di salute33Pubblicazioni 24/10/202024/10/2020Nessun commento

Giancarlo Agnelli et al. N Engl J Med. 2020 Abstract Background: Recent guidelines recommend consideration of the use of oral edoxaban or rivaroxaban for the treatment of venous thromboembolism in patients with cancer. However, the benefit of these oral agents is limited by the increased risk of bleeding associated with their use. Methods: This was a multinational, …

Leggi tutto “Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer”

Cookie	Durata	Descrizione
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Informativa